What does "sterile" actually mean for a research vial that arrived in a padded envelope?

Vendor listings say "sterile" and "sterile filtered" more or less interchangeably, and I have started to suspect these words are doing no work at all. I would like to know what claims are actually being made and what I should ask for.

Concretely, I have a lyophilised research vial. The listing said sterile filtered. The COA covers identity by mass spec and purity by HPLC, and says nothing about sterility or endotoxin. It arrived in a bubble mailer, no temperature control, twelve days in transit.

My questions:

• What is the difference between "sterile filtered" as a process description and "sterile" as a product claim? I assume these are not the same.
• Is there a test that would actually substantiate a sterility claim, and would a supplier plausibly have run it?
• How does this interact with the fact that I am then working on a kitchen counter with no laminar flow hood? At some point my own environment dominates and the vial's original status stops mattering.
• Where do visible and subvisible particulates fit — is there a standard for how clean the solution should look?

Research use only, not for human use. I am trying to calibrate what is knowable rather than looking for permission.

"Sterile filtered" describes a step. "Sterile" is a claim about the container in your hand, and only a test regime substantiates it. They are routinely conflated in listings and the gap between them is where all your uncertainty lives.

What sterility means formally

Sterility is not a binary property you can inspect — it is a probability statement. A terminally sterilised product is manufactured to a sterility assurance level, conventionally 10^-6, meaning no more than one unit in a million is expected to be non-sterile. That number comes from a validated lethal process applied to the sealed final container: moist heat, dry heat, irradiation.

Lyophilised peptide cannot be terminally sterilised by heat, so the route is aseptic processing: sterile-filter the bulk solution, then fill, part-stopper, lyophilise and seal in a classified environment. That process gives no 10^-6 guarantee by physics; assurance comes from environmental monitoring, media fills, and end-product testing. Which means the phrase "sterile filtered" tells you that one step of an aseptic process was performed and tells you nothing about the rest of it.

What test would substantiate the claim

Two, and they are separate:

• Sterility test (the compendial sterility chapter): membrane filtration or direct inoculation of product into growth media, incubated 14 days. It is destructive, it consumes units, it takes two weeks, and it has poor statistical power — a pass on a small sample from a large batch is a weak signal, which is why it is a release test and not the basis of assurance.
• Bacterial endotoxins test (the BET chapter): LAL-based, quantitative, results in hours, expressed in endotoxin units per container or per milligram. This is the more informative one to ask for, because it is quick, cheap, quantitative, and it detects the residue of contamination that happened before any filtration step.

Would a research-material supplier have run these? Some will produce an endotoxin figure on request. Sterility testing on research-grade lyophilised peptide is much less common, because the two-week destructive test does not fit a research supply chain. A COA that covers identity by mass spec and purity by HPLC — which is what yours does — is a chemistry certificate. It is not a microbiological one, and its silence on sterility and endotoxin should be read as silence, not as a pass.

The practical ask is one line: "Can you provide the endotoxin result for this lot, in EU per vial or EU per mg?" You will learn something from the answer either way.

Your environment versus the vial's history

You are right that this dominates, and the framing that helps is critical site and first air. The critical sites in your workflow are the septum surface, the needle, the syringe tip, and the interior of any cap you remove. A laminar flow hood works by ensuring that the air touching those surfaces has come directly from a HEPA filter without passing over anything else. A kitchen counter provides no such guarantee: the air is moving, it carries skin flakes and textile fibres, and anything you set down picks up whatever was on the surface.

What you can do without a hood, in descending order of value:

1. Work in still air. Close windows, turn off fans, do not work where a door has just opened. Moving air is the transport mechanism.
2. Never let a critical site touch anything. Do not put a needle down. Do not set a cap face-down. Do not rest a syringe on the bench.
3. Clean the work surface, wash hands, and keep the number of open-container seconds as small as possible. Every step you have to improvise mid-procedure is time with a critical site exposed, so lay everything out first.
4. Do not talk over open material. This sounds fussy; it is the single largest local source of viable particles.

None of this makes anything sterile. It reduces the bioburden you introduce, which combined with a preserved diluent and a short in-use window is the actual harm-reduction stack available to you.

Particulates

There is a standard, and it is a useful mental benchmark. The compendial requirement for injections is that they be essentially free of particles observable on visual inspection, assessed under defined illumination against black and white backgrounds. Separately, subvisible particle limits for small-volume injections are set by light obscuration at not more than 6,000 particles of 10 µm or larger and not more than 600 of 25 µm or larger per container.

You cannot measure the subvisible number. You can absolutely do the visible inspection, and doing it the compendial way — controlled lighting, black background then white, gentle swirl, no shaking — is far more sensitive than glancing at a vial under a kitchen light. If you see anything, that is a discard question, because "essentially free of visible particulates" is the lowest bar in the whole system and a vial that fails it fails everything.

edited 15 Mar 2026 by loss_on_drying — fixed an arithmetic slip in the third paragraph

Direct answer to the "twelve days in a bubble mailer" part, which the accepted answer sets aside but is worth separating explicitly because people conflate the two failure modes constantly.

Shipping is a stability problem, not a sterility problem. A sealed vial with an intact crimp and an unpunctured septum is a closed container. Twelve days at whatever temperature a mail network provides does not compromise container closure integrity, and it does not let organisms in. What it does is expose the contents to heat and to humidity cycling.

For lyophilised powder both of those are relatively benign compared with what they do to solution — which is precisely why material ships as a dry cake rather than reconstituted. The dry state has very little mobile water, so hydrolytic degradation is slow. The things to actually check on arrival:

• Is the cake still a cake? A collapsed, shrunken or glassy melted-back cake indicates the product went above its collapse temperature or picked up moisture. That is a real signal about transit conditions.
• Is the crimp tight and the septum unmarked? Rotate the aluminium seal gently. It should not turn freely.
• Any liquid, anywhere? A partly liquefied cake means significant moisture ingress or a temperature excursion, and it is the one finding that turns a stability question into a discard question.

What is not informative: the absence of a cold pack. Ambient shipping of lyophilised peptide is normal and expected, and a warm gel pack in the package tells you nothing except that somebody spent money on packaging. If anything, a melted gel pack sitting against a vial for twelve days is a humidity liability rather than a benefit.

One thing to add about vendor language, since the question is partly about how to read a listing.

The phrases you will see, ranked from most to least meaningful:

Note that the bottom three are the ones that appear most often, and that "99 % pure" is a chromatographic purity statement which is entirely orthogonal to sterility — a 99.5 % pure peptide can be heavily contaminated, because organisms and endotoxin do not show up as HPLC peak area in any meaningful way at these levels.

The independent testing services are worth mentioning for what they do and do not cover. Janoshik, Medutest, PeptideMeter and VendorInvestigate publish third-party results on supplier material, and those reports are genuinely useful for identity, purity and content assay. They are chemistry reports. If you want a microbiological attribute, it has to be asked for as such, and the answer will come from the supplier's own release testing or from nowhere.